SCHEDULE 13D/A//SEC Filing
X4 Pharmaceuticals, Inc SCHEDULE 13D/A
Accession 0001072613-25-000643
CIK 0001917895other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:54 PM ET
Size
94.5 KB
Accession
0001072613-25-000643
Issuer
Growth Equity Opportunities 18 VGE, LLC
CIK 0001917895
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001917895
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:54 PM ET
- Size
- 94.5 KB